BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28593503)

  • 21. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.
    Liu K; Zhang Y; Zhang C; Zhang Q; Li J; Xiao F; Li Y; Zhang R; Dou D; Liang J; Qin J; Lin Z; Zhao D; Jiang M; Liang Z; Su J; Gupta VP; He M; Yang X
    Oncotarget; 2016 Aug; 7(35):56798-56810. PubMed ID: 27462864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas.
    Cui C; Lu Z; Yang L; Gao Y; Liu W; Gu L; Yang C; Wilson J; Zhang Z; Xing B; Deng D; Sun ZS
    Mol Carcinog; 2016 Jul; 55(7):1163-74. PubMed ID: 26138747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
    Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma.
    Di JZ; Han XD; Gu WY; Wang Y; Zheng Q; Zhang P; Wu HM; Zhu ZZ
    J Zhejiang Univ Sci B; 2011 Oct; 12(10):805-11. PubMed ID: 21960343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate.
    Udali S; Guarini P; Moruzzi S; Ruzzenente A; Tammen SA; Guglielmi A; Conci S; Pattini P; Olivieri O; Corrocher R; Choi SW; Friso S
    Hepatology; 2015 Aug; 62(2):496-504. PubMed ID: 25833413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
    Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
    Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between folate status and tumour progression in patients with hepatocellular carcinoma.
    Kuo CS; Lin CY; Wu MY; Lu CL; Huang RF
    Br J Nutr; 2008 Sep; 100(3):596-602. PubMed ID: 18275623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort.
    Welzel TM; Katki HA; Sakoda LC; Evans AA; London WT; Chen G; O'Broin S; Shen FM; Lin WY; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1279-82. PubMed ID: 17548697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential hypermethylation of the VTRNA2-1 promoter in hepatocellular carcinoma as a prognostic factor: Tumor marker prognostic study.
    Yu MC; Lee CW; Lin CH; Wu CH; Lee YS; Tsai CL; Tsai CN
    Int J Surg; 2020 Jul; 79():282-289. PubMed ID: 32417463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SNHG and UCA1 as prognostic molecular biomarkers in hepatocellular carcinoma: recent research and meta-analysis.
    Li J; Gao J; Kan A; Hao T; Huang L
    Minerva Med; 2017 Dec; 108(6):568-574. PubMed ID: 28466631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study.
    Wu HC; Wang Q; Yang HI; Tsai WY; Chen CJ; Santella RM
    Carcinogenesis; 2012 Jul; 33(7):1340-5. PubMed ID: 22581841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers.
    Moruzzi S; Udali S; Ruzzenente A; Guglielmi A; Guarini P; Martinelli N; Conci S; Mazzi F; Pattini P; Tammen SA; Olivieri O; Pizzolo F; Choi SW; Friso S
    PLoS One; 2016; 11(12):e0167534. PubMed ID: 27936032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
    He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L
    Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.